Drugs / Hepatitis E vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02603055 | Jul 2015 → Apr 2016 | hepatitis E virus infection | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatitis E vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02603055 ↗ |
| Modality | Vaccine | “30μg/0.5ml Hepatitis E vaccine” NCT02603055 ↗ |